Unique ID issued by UMIN | UMIN000040188 |
---|---|
Receipt number | R000045825 |
Scientific Title | Chloroquine and hydroxychloroquine for treatment of COVID-19: systematic review of randomized and non-randomized controlled trial |
Date of disclosure of the study information | 2020/04/17 |
Last modified on | 2021/12/20 12:21:02 |
Chloroquine and hydroxychloroquine for treatment of COVID-19: systematic review of randomized and non-randomized controlled trial
Chloroquine and hydroxychloroquine for treatment of COVID-19: systematic review of randomized and non-randomized controlled trial
Chloroquine and hydroxychloroquine for treatment of COVID-19: systematic review of randomized and non-randomized controlled trial
Chloroquine and hydroxychloroquine for treatment of COVID-19: systematic review of randomized and non-randomized controlled trial
Japan | North America |
COVID-19
Medicine in general | Infectious disease |
Others
NO
To investigate the impact of CQ/HCQ on COVID-19
Efficacy
All cause death (odds ratio). Viral clearance on day 7
Others,meta-analysis etc
Not applicable |
Not applicable |
Male and Female
COVID-19
None
1st name | Nobuyuki |
Middle name | |
Last name | Horita |
Yokohama City University School of Medicine
Department of Pulmonology
236-0004
3-9 Fukuura Kanazawa Yokohama
0457872800
horitano@yokohama-cu.ac.jp
1st name | Nobuyuki |
Middle name | |
Last name | Horita |
Yokohama City University School of Medicine
Department of Pulmonology
236-0004
3-9 Fukuura Kanazawa Yokohama
0457872800
horitano@yokohama-cu.ac.jp
Yokohama City University School of Medicine
Yokohama City University School of Medicine
Other
Yokohama City University School of Medicine
3-9 Fukuura Kanazawa Yokohama
0457872800
horitano@yokohama-cu.ac.jp
NO
2020 | Year | 04 | Month | 17 | Day |
Published
2063
Please see:
J Thorac Dis. 2021 Jan;13(1):202-212.
2021 | Year | 12 | Month | 20 | Day |
Please see:
J Thorac Dis. 2021 Jan;13(1):202-212.
Please see:
J Thorac Dis. 2021 Jan;13(1):202-212.
Please see:
J Thorac Dis. 2021 Jan;13(1):202-212.
Please see:
J Thorac Dis. 2021 Jan;13(1):202-212.
Please see:
J Thorac Dis. 2021 Jan;13(1):202-212.
Please see:
J Thorac Dis. 2021 Jan;13(1):202-212.
Please see:
J Thorac Dis. 2021 Jan;13(1):202-212.
Main results already published
2020 | Year | 04 | Month | 17 | Day |
2020 | Year | 04 | Month | 17 | Day |
2020 | Year | 04 | Month | 17 | Day |
2021 | Year | 03 | Month | 31 | Day |
Search:
PubMed, Web of Science, Cochrane database, EMBASE, and MedRxiv will be searched on April 15, 2020. Hand search will be also done.
Type of study
Randomized and non-randomized controlled trial.
A randomized study with preliminary or interim analysis will be allowed.
Outcome
Viral clearance. Symptom alleviation. CT improvement. Disease progression. Any AE. Severe AE. Death from any cause.
Patient
COVID-19 patient confirmed with PCR and strongly suspected based on clinical information.
Treatment
Chloroquine and Hydroxychloroquine with or without Azithromycin
2020 | Year | 04 | Month | 17 | Day |
2021 | Year | 12 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045825